Sunshine Biopharma Inc (SBFM)
1.22
-0.22
(-15.28%)
USD |
NASDAQ |
Apr 23, 16:00
1.17
-0.05
(-4.10%)
After-Hours: 20:00
Sunshine Biopharma Total Liabilities (Quarterly): 6.140M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.140M |
| September 30, 2023 | 5.687M |
| June 30, 2023 | 5.300M |
| March 31, 2023 | 7.562M |
| December 31, 2022 | 7.616M |
| September 30, 2022 | 0.4802M |
| June 30, 2022 | 0.1047M |
| March 31, 2022 | 0.0952M |
| December 31, 2021 | 1.991M |
| September 30, 2021 | 3.676M |
| June 30, 2021 | 2.690M |
| March 31, 2021 | 2.943M |
| December 31, 2020 | 2.000M |
| September 30, 2020 | 1.105M |
| June 30, 2020 | 0.7494M |
| March 31, 2020 | 0.7723M |
| December 31, 2019 | 0.8335M |
| September 30, 2019 | 0.8892M |
| June 30, 2019 | 0.9257M |
| March 31, 2019 | 1.459M |
| December 31, 2018 | 1.202M |
| September 30, 2018 | 1.060M |
| June 30, 2018 | 1.446M |
| March 31, 2018 | 1.503M |
| December 31, 2017 | 0.8308M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.6099M |
| June 30, 2017 | 0.7806M |
| March 31, 2017 | 0.2845M |
| December 31, 2016 | 0.2741M |
| September 30, 2016 | 0.2767M |
| June 30, 2016 | 1.214M |
| March 31, 2016 | 1.186M |
| December 31, 2015 | 1.270M |
| September 30, 2015 | 0.4696M |
| June 30, 2015 | 0.4361M |
| March 31, 2015 | 0.3792M |
| December 31, 2014 | 0.531M |
| September 30, 2014 | 0.4566M |
| June 30, 2014 | 0.3823M |
| March 31, 2014 | 0.185M |
| December 31, 2013 | 0.0389M |
| September 30, 2013 | 0.0235M |
| June 30, 2013 | 0.0147M |
| March 31, 2013 | 0.0224M |
| December 31, 2012 | 0.0644M |
| September 30, 2012 | 0.0149M |
| June 30, 2012 | 0.0294M |
| March 31, 2012 | 0.0205M |
| December 31, 2011 | 0.0034M |
| September 30, 2011 | 0.0045M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0952M
Minimum
Mar 2022
7.616M
Maximum
Dec 2022
2.714M
Average
1.991M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Lexaria Bioscience Corp | 0.2042M |
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
| Xenon Pharmaceuticals Inc | 36.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.35M |
| Shareholders Equity (Quarterly) | 21.21M |
| Current Ratio | 4.483 |